Edico Genome

United States of America

Acquired By: Illumina Inc.

Edico Genome

Edico Genome has created an end-to-end platform solution for analysis of next-generation sequencing data, DRAGEN™, which speeds whole genome data analysis from hours to minutes while maintaining high accuracy and reducing costs. Top clinicians and researchers are utilizing the platform to achieve faster diagnoses for critically ill newborns, cancer patients and expecting parents waiting on prenatal tests, and faster results for scientists and drug developers.

Private/Public:private
Phone:+1-858-260-5234
Email:[email protected]
Website:http://www.edicogenome.com
Address:3344 North Torrey Pines Court, Plaza LevelLa Jolla, CA 92037, United States of America

2013
Since
1
Country
1
Top Service Category
5
Sub-Service Categories

Top Services

Categories


Therapeutic Categories

Main Disease Areas


Business Sectors

For Services/Products


Development Stages

For Services/Products


United States of America

Analytical Equipment

Manufacturing Equipment

Facility Inspection/License Status

Phone:+1-858-260-5234
Email:[email protected]
Website:http://www.edicogenome.com
Address:3344 North Torrey Pines Court, Plaza LevelLa Jolla, CA 92037